Skip to content

SEC Filing Details

Document Details

Form
Filing Date
Dec 21, 2018
Document Date
Dec 20, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Esperion Therapeutics, Inc.
Issuer
ESPERION THERAPEUTICS, INC.
Filer
Glickman Mark A